Triple Elimination Framework promotes an integrated, people-first approach across four key pillars—interventions, quality, impact, and sustainability
The global health community...
U.S. pharmaceutical company Eli Lilly plans to introduce its blockbuster drug ‘Tirzepatide‘ to India in 2025. The drug, renowned for treating type 2...